CorMedix (CRMD) Misses Q4 EPS by 7c
Tweet
Share
E-mailGet Alerts CRMD Hot Sheet
Join SI Premium – FREE
CorMedix (NASDAQ: CRMD) reported Q4 EPS of ($0.26), $0.07 worse than the analyst estimate of ($0.19).
For earnings history and earnings-related data on CorMedix (CRMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
- Barclays Downgrades Brown Forman (BF-B) to Equalweight
- Barclays Upgrades United Internet AG (UTDI:GR) (UDIRY) to Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
